http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017214367-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9adfd8615849e9c22cdc691df7f8b6ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6702b1bad9eed1a024aa9040f9fd6602 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f90eb30d9fc1f535740cf3aef804148e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e85bf4cbea0738a92ab6da2d719191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6820cffd325f746be061e3865a05b816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82602cac507f91df923678e45d786405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d52b2d1069bdad9a400a3a1c9eaaab9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708b5062baf26df345c42512710bda07 |
| publicationDate | 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017214367-A |
| titleOfInvention | Pharmaceutical composition for the treatment of malignant lymphoma |
| abstract | An object of the present invention is to provide a pharmaceutical composition for treating malignant lymphoma and a method for treating malignant lymphoma using the pharmaceutical composition. The object of the present invention is also to provide a companion diagnostic method and a kit therefor for the use of said pharmaceutical composition or treatment method. A pharmaceutical composition comprising an ERα antagonist for treating malignant lymphoma is provided. Also provided is a method for treating malignant lymphoma comprising administering an ERα antagonist to a subject in need of treatment for malignant lymphoma. Furthermore, a companion diagnostic method and a kit therefor for use of the pharmaceutical composition or treatment method, comprising measuring the expression level of estrogen receptor α in a lymphoid tumor cell of a subject are provided. [Selection] Figure 4 |
| priorityDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.